JP2020534830A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020534830A5 JP2020534830A5 JP2020516462A JP2020516462A JP2020534830A5 JP 2020534830 A5 JP2020534830 A5 JP 2020534830A5 JP 2020516462 A JP2020516462 A JP 2020516462A JP 2020516462 A JP2020516462 A JP 2020516462A JP 2020534830 A5 JP2020534830 A5 JP 2020534830A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antigen
- antibody
- variable region
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023105809A JP2023126851A (ja) | 2017-09-21 | 2023-06-28 | 新規抗ＣＤ３ε抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2017102622 | 2017-09-21 | ||
| CNPCT/CN2017/102622 | 2017-09-21 | ||
| PCT/CN2018/106618 WO2019057099A1 (en) | 2017-09-21 | 2018-09-20 | NOVEL ANTI-CD3EPSILON ANTIBODIES |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023105809A Division JP2023126851A (ja) | 2017-09-21 | 2023-06-28 | 新規抗ＣＤ３ε抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020534830A JP2020534830A (ja) | 2020-12-03 |
| JP2020534830A5 true JP2020534830A5 (US20080131398A1-20080605-C00009.png) | 2021-10-28 |
| JP7305624B2 JP7305624B2 (ja) | 2023-07-10 |
Family
ID=65811028
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516462A Active JP7305624B2 (ja) | 2017-09-21 | 2018-09-20 | 新規抗ＣＤ３ε抗体 |
| JP2023105809A Pending JP2023126851A (ja) | 2017-09-21 | 2023-06-28 | 新規抗ＣＤ３ε抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023105809A Pending JP2023126851A (ja) | 2017-09-21 | 2023-06-28 | 新規抗ＣＤ３ε抗体 |
Country Status (16)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019057122A1 (en) | 2017-09-22 | 2019-03-28 | Wuxi Biologics (Shanghai) Co., Ltd. | NEW BISPECIFIC POLYPEPTIDE COMPLEXES |
| TWI732136B (zh) * | 2017-09-22 | 2021-07-01 | 大陸商上海藥明生物技術有限公司 | 新型雙特異性cd3/cd19多肽複合物 |
| JP2022536247A (ja) * | 2019-06-07 | 2022-08-15 | アディマブ・リミテッド・ライアビリティ・カンパニー | 高アフィニティ抗ｃｄ３抗体、ならびにその作製方法及び使用方法 |
| US20230067182A1 (en) * | 2019-11-29 | 2023-03-02 | Boe Technology Group Co., Ltd. | Data Processing Device and Method, and Computer Readable Storage Medium |
| EP4157459A1 (en) * | 2020-05-27 | 2023-04-05 | Janssen Biotech, Inc. | Proteins comprising cd3 antigen binding domains and uses thereof |
| CA3217391A1 (en) * | 2020-07-27 | 2022-02-03 | Youwei ZHU | Formulation of novel bispecific anti-cd3/cd20 polypeptide complex |
| US11795224B2 (en) * | 2021-03-24 | 2023-10-24 | China Medical University Hospital | Anti-T-cell nanobody and nucleic acid encoding sequence thereof, and uses of the same |
| CN115536740A (zh) * | 2021-06-30 | 2022-12-30 | 苏州方德门达新药开发有限公司 | 介导细胞内有效滞留cd3的空间构象表位及其应用 |
| CN115558023A (zh) * | 2021-07-02 | 2023-01-03 | 安源医药科技（上海）有限公司 | 抗cd3抗体及其用途 |
| WO2023173258A1 (zh) * | 2022-03-14 | 2023-09-21 | 成都盛世君联生物技术有限公司 | 一种抗cd3抗体及其制备方法和用途 |
| CN115286715B (zh) * | 2022-05-18 | 2023-05-23 | 上海百英生物科技股份有限公司 | 一种抗cd3的纳米抗体或其抗原结合部分及其制备方法 |
| WO2024109792A1 (en) | 2022-11-24 | 2024-05-30 | Wuxi Biologics (Shanghai) Co., Ltd. | Psma antibodies and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020142000A1 (en) * | 1999-01-15 | 2002-10-03 | Digan Mary Ellen | Anti-CD3 immunotoxins and therapeutic uses therefor |
| ES2856451T3 (es) * | 2005-10-11 | 2021-09-27 | Amgen Res Munich Gmbh | Composiciones que comprenden anticuerpos específicos para diferentes especies, y usos de las mismas |
| EP3461842A1 (en) | 2007-04-03 | 2019-04-03 | Amgen Research (Munich) GmbH | Cross-species-specific binding domain |
| CA2682626A1 (en) * | 2007-04-03 | 2008-10-09 | Micromet Ag | Cross-species-specific bispecific binders |
| WO2011109588A1 (en) * | 2010-03-03 | 2011-09-09 | Health Research Inc. | Novel cd3 epsilon immunogens and antibodies |
| CN105408357A (zh) | 2013-05-28 | 2016-03-16 | 努玛有限公司 | 新型抗体 |
| PT3083689T (pt) | 2013-12-17 | 2020-08-27 | Genentech Inc | Anticorpos anti-cd3 e métodos de utilização |
| JP6738285B2 (ja) * | 2014-05-28 | 2020-08-12 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | ヒト及びカニクイザルｃｄ３イプシロンに結合する抗体 |
| CA2963692A1 (en) * | 2014-10-09 | 2016-04-14 | Engmab Ag | Bispecific antibodies against cd3epsilon and ror1 |
| MY191964A (en) | 2015-01-23 | 2022-07-21 | Sanofi Sa | Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123 |
-
2018
- 2018-09-20 KR KR1020207011016A patent/KR20200055052A/ko not_active Application Discontinuation
- 2018-09-20 EA EA202090800A patent/EA202090800A1/ru unknown
- 2018-09-20 BR BR112020004992-1A patent/BR112020004992A2/pt unknown
- 2018-09-20 EP EP18859373.5A patent/EP3684806A4/en active Pending
- 2018-09-20 CA CA3074130A patent/CA3074130A1/en active Pending
- 2018-09-20 CN CN202211326811.1A patent/CN115991777A/zh active Pending
- 2018-09-20 CN CN201880056557.3A patent/CN111108119B/zh active Active
- 2018-09-20 AU AU2018336519A patent/AU2018336519A1/en active Pending
- 2018-09-20 MY MYPI2020001058A patent/MY199530A/en unknown
- 2018-09-20 MX MX2020003087A patent/MX2020003087A/es unknown
- 2018-09-20 US US16/649,149 patent/US11440962B2/en active Active
- 2018-09-20 TW TW107133192A patent/TWI820041B/zh active
- 2018-09-20 SG SG11202001358RA patent/SG11202001358RA/en unknown
- 2018-09-20 JP JP2020516462A patent/JP7305624B2/ja active Active
- 2018-09-20 WO PCT/CN2018/106618 patent/WO2019057099A1/en active Application Filing
-
2020
- 2020-02-28 ZA ZA2020/01314A patent/ZA202001314B/en unknown
- 2020-03-18 IL IL273393A patent/IL273393A/en unknown
-
2022
- 2022-08-02 US US17/816,732 patent/US20230192850A1/en active Pending
-
2023
- 2023-06-28 JP JP2023105809A patent/JP2023126851A/ja active Pending
